Clinical Trial Update: Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating intravenous palonosetron for prevention of postoperative nausea and vomiting in pediatric patients; the update reports safety and effic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Aloxi (palonosetron hydrochloride)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Postoperative Nausea and Vomiting | Phase 3 | Status: COMPLETED | Results posted: 2014-07-30